Genetic Toxicology Testing of Biopharmaceuticals

Preclinical Safety Evaluation of Biopharmaceuticals: A Science-Based Approach to Facilitating Clinical Trials

Volumn , Issue , 2007, Pages 337-341

  Jacobson Kram, David ^a   Ghantous, Hanan ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Biopharmaceutical genetic toxicology testing; Genetic toxicity decision tree and biopharmaceuticals; Genotoxicity assay 44 FDA approved biopharmaceuticals

Indexed keywords

EID: 77955294254     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470292549.ch15     Document Type: Chapter

References (8)

1. ICH S2B . A Standard Battery for Genotoxicity Testing of Pharmaceuticals, 1997 .
2. Obe G , Jonas R , Schmidt S. The restriction endonuclease Alu I induces chromosomal aberrations in human peripheral blood lymphocytes in vitro . Mutat Res 1986 ; 163: 271 - 5 .
3. Vasudev V , Obe G. Evidence for a recptor - mediated endocytosis of Alu I in Chinese hamster ovary cells . Mutat Res 1988 ; 197: 109 - 16 .
4. Gocke E , Albertini S , Brendel - Schwaab S , Muller L , Suter W , et al. Genotoxicity testing of biotechnology - derived products. Report of a GUM task force . Mutat Res 1999 ; 436: 137 - 56 .
5. FDA Draft Guidance for Industry, Nonclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals (in preparation).
6. Yajima N , Kurata Y , Imai E , Sawai T , Takeshita Y. Genotoxicty of genetic recombinant erythropoietin in a novel test system . Mutagenesis 1993 ; 8: 231 - 6 .
7. Yajima N , Kurata Y , Sawai T , Takeshita Y. Comparative studies in induction of micronuclei by three genetically recombinant and urinary human erythropoietins . Mutagenesis 2003 ; 8: 237 - 41 .
8. Yajima N , Kurata Y , Sawai T , Takeshita Y. Induction of micronucleated erythrocytes by recombinant human erythropoietin . Mutagenesis 2003 ; 8: 221 - 9 .